CY1119957T1 - Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος - Google Patents

Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος

Info

Publication number
CY1119957T1
CY1119957T1 CY20181100232T CY181100232T CY1119957T1 CY 1119957 T1 CY1119957 T1 CY 1119957T1 CY 20181100232 T CY20181100232 T CY 20181100232T CY 181100232 T CY181100232 T CY 181100232T CY 1119957 T1 CY1119957 T1 CY 1119957T1
Authority
CY
Cyprus
Prior art keywords
treatment
announced
patients
pharmaceutical preparation
preparations
Prior art date
Application number
CY20181100232T
Other languages
Greek (el)
English (en)
Inventor
Sylvain PERRUCHE
Philippe SAAS
Francis Bonnefoy
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm) filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of CY1119957T1 publication Critical patent/CY1119957T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20181100232T 2013-01-07 2018-02-27 Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος CY1119957T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305009 2013-01-07
PCT/EP2014/050167 WO2014106666A1 (en) 2013-01-07 2014-01-07 Disease therapy using a tolerogenic pharmaceutical preparation
EP14700238.0A EP2941257B1 (de) 2013-01-07 2014-01-07 Krankheitstherapie mit einer tolerogenen pharmazeutischen zubereitung

Publications (1)

Publication Number Publication Date
CY1119957T1 true CY1119957T1 (el) 2018-12-12

Family

ID=47559360

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100232T CY1119957T1 (el) 2013-01-07 2018-02-27 Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος

Country Status (14)

Country Link
US (2) US10653758B2 (de)
EP (1) EP2941257B1 (de)
CY (1) CY1119957T1 (de)
DK (1) DK2941257T3 (de)
ES (1) ES2657675T3 (de)
HR (1) HRP20180359T1 (de)
HU (1) HUE038211T2 (de)
LT (1) LT2941257T (de)
NO (1) NO2941257T3 (de)
PL (1) PL2941257T3 (de)
PT (1) PT2941257T (de)
RS (1) RS56906B1 (de)
SI (1) SI2941257T1 (de)
WO (1) WO2014106666A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
IL303543A (en) 2015-02-18 2023-08-01 Enlivex Therapeutics Rdo Ltd Combined immunotherapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
JP6803339B2 (ja) 2015-04-21 2020-12-23 エンリヴェックス セラピューティクス リミテッド 治療用のプールされた血液アポトーシス細胞調製物及びそれらの使用
KR20180110141A (ko) 2016-02-18 2018-10-08 엔리벡스 테라퓨틱스 리미티드 암을 치료하기 위한 면역요법과 사이토카인 조절 요법의 조합
FR3082730B1 (fr) * 2018-06-21 2022-04-22 Med Inn Pharma Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
WO2006120439A2 (en) * 2005-05-10 2006-11-16 Avaris Ab Cellular vaccine and use thereof
WO2008043018A1 (en) * 2006-10-04 2008-04-10 Dana-Farber Cancer Institute, Inc. Tumor immunity
EP2201954A1 (de) * 2008-12-18 2010-06-30 Aposcience AG Pharmazeutisches Präparat

Also Published As

Publication number Publication date
DK2941257T3 (en) 2018-02-26
SI2941257T1 (en) 2018-03-30
PL2941257T3 (pl) 2018-05-30
HRP20180359T1 (hr) 2018-05-04
US20150343039A1 (en) 2015-12-03
US11793865B2 (en) 2023-10-24
EP2941257A1 (de) 2015-11-11
LT2941257T (lt) 2018-02-26
RS56906B1 (sr) 2018-05-31
EP2941257B1 (de) 2017-11-29
NO2941257T3 (de) 2018-04-28
ES2657675T3 (es) 2018-03-06
WO2014106666A1 (en) 2014-07-10
PT2941257T (pt) 2018-03-06
US20200237884A1 (en) 2020-07-30
HUE038211T2 (hu) 2018-10-29
US10653758B2 (en) 2020-05-19

Similar Documents

Publication Publication Date Title
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
CY1124436T1 (el) Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια
CY1120862T1 (el) Παραγοντες επαγωγης αποπτωσης για τη θεραπευτικη αγωγη καρκινου και ανοσων και αυτοανοσων ασθενειων
CY1119058T1 (el) Ενωσεις ιμιδαζοπυρρολιδινονης
EA201891186A1 (ru) Антитела, нейтрализующие вирус иммунодефицита человека
EA201890204A1 (ru) Антибактериальные соединения
CY1121736T1 (el) Άλατα aramchol
EA201590343A1 (ru) Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний
EA201691582A1 (ru) Новые фармацевтические препараты
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201500207A1 (ru) Гетероароматические соединения в качестве ингибиторов втк
EA201591887A1 (ru) Макроциклические деазаоксипурины для лечения вирусных инфекций
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
BR112017000898A2 (pt) oritavancina de alta pureza e método de produção da mesma
CY1121105T1 (el) Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
CY1122708T1 (el) Ενωσεις οξα-διαζασπειρο με δραση εναντι του πονου
MD4763C1 (ro) Compoziţie farmaceutică
CY1120192T1 (el) Ενωσεις για την ενισχυση της γνωστικης λειτουργιας